Specialist

The closure of many open-ended property funds for only the second time in their history (we think) is a classic case of irrational investor decision-making, writes Guy Stephens, managing director of Rowan Dartington Signature.

Overuse of antibiotics around the globe has created a worrying increase in resistance to many commonly used drugs, writes Carl Harald Janson, lead manager on the International Biotechnology trust.

One of the key differentiating factors of technology - and why it is such an exciting place to invest - is that it has the power to create new markets. Certainly, this may happen sporadically in retailing, or construction, or oil and gas, but permanent,...

The long-promised robotics revolution has arrived. True, it is not quite what people imagined only a few decades ago. The humanoid automata beloved by science fiction are still at best fringe novelties.

Few opportunities in electricity sector

From both issuers and investors

Deadline of 27 June

Q1 slowdown

Value currently underperforming

High conviction portfolio